1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hydronephrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulbins, E; Rauterberg, EW; Schlottmann, K; Steinhausen, M | 1 |
| Hsueh, W; Needleman, P; Spaethe, SM | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hydronephrosis
| Article | Year |
|---|---|
Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys.
Topics: Animals; Antibodies; Complement C5a; Female; Glomerular Filtration Rate; Hydronephrosis; Indazoles; Neutrophils; Phenylacetates; Platelet Activating Factor; Rats; Rats, Wistar; Recombinant Proteins; Reference Values; Renal Circulation; SRS-A; Sulfonamides; Thromboxanes; Vasoconstriction | 1993 |
Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Ethoxyquin; Fatty Acids, Nonesterified; Furans; Hydronephrosis; Inflammation; Kidney; Leukotriene B4; Lipoxygenase Inhibitors; Male; Perfusion; Platelet Activating Factor; Quinolines; Rabbits; Thiophenes; Thromboxane-A Synthase | 1989 |